In addition, sialylated HMOs suppressed inflammatory cytokine (IL-1β, TNF-α and IL-6) production and reduced NEC incidence and pathological damages in inflamed ileum of NEC rats in vivo [38]. This evidence concerns the gene IL1B and necrotizing enterocolitis.